# FDA 483 - CSL Plasma Inc. - August 07, 2025

Source: https://www.keypedia.com/records/483/csl-plasma-inc/ca22f514-39e4-48f5-b508-13155313ab99

> FDA 483 for CSL Plasma Inc. on August 07, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: CSL Plasma Inc.
- Inspection Date: 2025-08-07
- Product Type: biologics
- Office Name: Denver District Office
- Summary: CSL Plasma Inc. in Grand Junction, CO, a plasma center, was cited for failing to maintain adequate records of transfusion reaction reports and complaints. Specifically, the firm did not address a public complaint regarding a significant infiltration during a donation, and there was no evidence of an investigation or justification for its absence. This indicates a lapse in their complaint handling and record-keeping procedures.

## Related Officers

- [Conor J. Mccarron](https://www.keypedia.com/people/conor-j-mccarron/280401e4-b080-4ba8-ab35-d3b16e91c2b1)

Company: https://www.keypedia.com/companies/csl-plasma-inc/5f271052-7d17-4ed5-922b-00267b8d77fb

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face